Chargement en cours...
Lipoic acid in secondary progressive MS: A randomized controlled pilot trial
OBJECTIVE: To determine whether lipoic acid (LA), an endogenously produced antioxidant, slowed the whole-brain atrophy rate and was safe in secondary progressive MS (SPMS). METHODS: Patients with SPMS aged 40–70 years enrolled in a single center, 2-year, double-blind, randomized trial of daily oral...
Enregistré dans:
| Publié dans: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Auteurs principaux: | , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Lippincott Williams & Wilkins
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5489387/ https://ncbi.nlm.nih.gov/pubmed/28680916 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000374 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|